title: Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice.
abstract: Tissue factor (TF) is the membrane receptor of the serine protease coagulation factor VIIa (FVIIa). Formation of the TF/FVIIa complex initiates the coagulation cascade. We used short hairpin RNA (shRNA)-mediated RNA interference to knock down TF expression in the human metastatic melanoma cell line LOX-L. After transfection with the shRNA construct, 3 stable clones with significantly downregulated TF expression were established. They exhibited decreased proliferation in vitro as determined by (14)C thymidine incorporation and soft agar assay. The in vivo metastatic potential was assessed in an experimental pulmonary metastasis model in which cells from different clones were injected into the tail vein of nude mice. The incidence of pulmonary tumors was significantly lower in mice receiving shRNA-expressing cells (33% +/- 15%) than in control mice injected with wild-type cells or cells stably transfected with empty expression vector (90% +/- 10%). The mice injected with TF-downregulated cells had markedly longer survival time (69 +/- 17 days) compared to the control mice (35.6 +/- 5 days; p = 0.03). Thus, reduction of TF levels in LOX-L cells significantly delayed and reduced lung tumor formation. As a first step in elucidating the molecular basis for this effect, we compared the global gene expression profile in TF-downregulated cells and control cells by using cDNA microarray analysis. Forty-four known human genes were found to be significantly upregulated (> 2-fold; p < 0.05) and 228 genes significantly downregulated (>or= 3-fold; p < 0.05) in TF-downregulated cells compared to control cells. The differentially expressed genes encode proteins functioning in transcription, translation, cell communication and cell growth/death. The results provide a basis for investigating molecular mechanisms underlying the effects of TF on the metastatic capacity of LOX-L melanoma cells.
authors.affiliation: Biotechnology Center of Oslo, University of Oslo, Oslo, Norway.
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Wang
authors.forename: Mengyu
authors.initials: M
authors.lastname: Wang
authors.forename: Mohammed
authors.initials: M
authors.lastname: Amarzguioui
authors.forename: Fang
authors.initials: F
authors.lastname: Liu
authors.forename: Øystein
authors.initials: Ø
authors.lastname: Fodstad
authors.forename: Hans
authors.initials: H
authors.lastname: Prydz
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004273:DNA, Neoplasm / Q000032:analysis; D015536:Down-Regulation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000378:metabolism* / Q000556:secondary*; D008545:Melanoma / Q000378:metabolism* / Q000556:secondary*; D051379:Mice; D008819:Mice, Nude; D020411:Oligonucleotide Array Sequence Analysis; D012334:RNA, Neoplasm / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism; D015996:Survival Rate; D013925:Thromboplastin / Q000235:genetics / Q000378:metabolism*; D014162:Transfection
chemical_list: D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D013925:Thromboplastin; C433550:HABP2 protein, human; C499020:Habp2 protein, mouse; D012697:Serine Endopeptidases